Kamada KMDA
NASDAQ KMDA
$8.31 +0.11 (+1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kamada (KMDA) Cash & Equivalents (2012 - 2026)

Updated

Kamada's Cash & Equivalents came in at $29.47 million for the quarter ended Jun 30, 2026, down 55.3% from $65.99 million a year earlier and down 10.5% from the prior quarter.

Analysis

Kamada (KMDA) Cash & Equivalents (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Kamada's Cash & Equivalents was $75.47 million, down 3.8% from the prior year.

  • Cash & Equivalents carries a five-year compound annual growth rate of 1.5% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Cash & Equivalents was $78.44 million in the year ended Dec 31, 2024 (+41.0%), $55.64 million in the year ended Dec 31, 2023 (+62.4%), $34.26 million in the year ended Dec 31, 2022 (+84.3%) and $18.59 million in the year ended Dec 31, 2021 (-73.5%).
  • The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Cash & Equivalents since the quarter ended Jun 30, 2023.
  • Year-over-year, Cash & Equivalents has declined for three consecutive quarters, with growth averaging 4.6% over the last eight quarters.
  • The fastest year-over-year change in Cash & Equivalents over five years came in the quarter ended Jun 30, 2024 (growth of 159.5%), and the weakest in the quarter ended Jun 30, 2022 (a decline of 100.0%).
  • Business Quant data shows KMDA's Cash & Equivalents at $32.92 million (quarter ended Mar 31, 2026), $75.47 million (quarter ended Dec 31, 2025) and $72 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Kamada 473.03 Mn 182.08 Mn 22.47 Mn 29.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.47 Mn
Mar 31, 2026 32.92 Mn
Dec 31, 2025 75.47 Mn
Sep 30, 2025 72.00 Mn
Jun 30, 2025 65.99 Mn
Mar 31, 2025 76.25 Mn
Dec 31, 2024 78.44 Mn
Sep 30, 2024 72.00 Mn
Jun 30, 2024 56.55 Mn
Mar 31, 2024 48.19 Mn
Dec 31, 2023 55.64 Mn
Sep 30, 2023 52.60 Mn
Jun 30, 2023 21.79 Mn
Mar 31, 2023 27.12 Mn
Dec 31, 2022 34.26 Mn
Sep 30, 2022 31.25 Mn
Jun 30, 2022 29,933.00
Mar 31, 2022 21.97 Mn
Dec 31, 2021 18.59 Mn
Sep 30, 2021 99.84 Mn
API Access

Kamada Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KMDA&period=max&api_key=YOUR_API_KEY